JD HEALTH (06618) surged 5.01% during intraday trading on Wednesday, driven by a wave of positive catalysts including a major health checkup service upgrade and a notable share buyback cancellation.

On July 24, the company announced a comprehensive upgrade of its health checkup services, introducing free re-examination within 180 days for over 200 positive indicators, a dedicated 1-on-1 private doctor team for checkup accompaniment, and closed-loop management covering diagnosis, testing, treatment, and medication for abnormal indicators. That same day, JD HEALTH opened its Beijing Ya'ao comprehensive outpatient clinic, a 5,800-square-meter facility offering health checkups, dental, and medical aesthetics services.

Additionally, on July 22, the company completed the cancellation of approximately 21.54 million repurchased shares at a total cost of roughly HK$839 million, reducing the issued share capital to about 3.19 billion shares. Goldman Sachs also recently maintained a Buy rating on the stock, citing continued market share expansion, further bolstering investor confidence.